Biodiversity2Drugs

The Biodiveristy2Drugs project, embedded within the BIODIVERSA+ theme, is dedicated to harnessing the biodiversity of nature-derived peptides for drug discovery, aiming to significantly improve human health. This initiative stands at the crossroads of science, human well-being, and sustainability, promising to deliver transformative impacts in drug discovery and environmental protection. By exploring the rich biodiversity of peptides across various organisms, we aim to map their unique chemical space and understand their evolutionary trajectories, thereby identifying novel therapeutic lead compounds, and providing a rationale for preservation of flora, fauna, and their habitats. At its core, the project is structured around six objectives: (1) Peptide Mining and Biodiversity (2) Peptide Evolution and Ecology (3) Computer-Assisted Ligand Mapping and Optimization (4) Green Peptide Chemistry Pipeline (5) Pharmacological Screening and Validation (6) Translation for Societal Impact This interdisciplinary endeavor leverages state-of-the-art nano-analytical, advanced computational, high-throughput pharmacological and green chemistry methodologies to ensure minimal environmental impact while maximizing therapeutic value. Our approach is designed to have a global impact, with the project engaging a consortium of 25 academic partners (from Europe, America, Asia and Australia), which extends by engaging stakeholders across health and environmental sectors for significant societal impact through advanced scientific research merged with sustainability and social responsibility. In summary, our project leverages nature-based solutions to tackle critical global health and environmental challenges. By advancing drug discovery while fostering an eco-conscious future, we highlight the essential link between the natural world and our collective well-being, aiming to transform the landscape of drug discovery and environmental conservation.